Skip to content

13F-HR filed by Atle Fund Management AB

Atle Fund Management AB filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-13, with 12 holding rows worth $85,642,000.

Accession
0000950123-17-010262
Filed
2017-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 12 entries on the cover page, a total value of $85,642,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $85,642,000 with VALUE read as thousands by filing date, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MCKESSON CORP COM58155Q103Stock68,600$10,538,000thousands by filing date
Elevance Health, Inc.036752103COM55,200$10,481,000thousands by filing date
ANIKA THERAPEUTICS INC035255108COM115,000$6,670,000thousands by filing date
CIGNA CORPORATION125509109COM35,200$6,580,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM60,812$6,569,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW47,900$6,522,000thousands by filing date
Pfizer Inc.717081103COM181,300$6,472,000thousands by filing date
WATERS CORP COM941848103Stock35,900$6,445,000thousands by filing date
BIOGEN INC COM09062X103Stock20,400$6,388,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW42,300$6,386,000thousands by filing date
Medtronic PlcG5960L103COM82,100$6,385,000thousands by filing date
Gilead Sciences,Inc.375558103COM76,600$6,206,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-17-010262this filing2017-11-13acceptance time not in the bulk data set